Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Older women with breast cancer: slow progress, great opportunity, now is the time.

Literature DB >> 22067402

Older women with breast cancer: slow progress, great opportunity, now is the time.

Hyman B Muss, Jan Busby-Whitehead.

Abstract

Entities: Disease Species

Mesh：

Year: 2011 PMID： 22067402 DOI： 10.1200/JCO.2011.38.6888

Source DB: PubMed Journal: J Clin Oncol ISSN： 0732-183X Impact factor: 44.544

Keyword Cloud
Cited

× No keyword cloud information.

6 in total

1. Patterns of locoregional treatment for nonmetastatic breast cancer by patient and health system factors.

Authors: Roger T Anderson; Cyllene R Morris; Gretchen Kimmick; Amy Trentham-Dietz; Fabian Camacho; Xiao-Cheng Wu; Susan A Sabatino; Steven T Fleming; Joseph Lipscomb
Journal: Cancer Date: 2014-11-04 Impact factor: 6.860

2. Eribulin monotherapy in patients aged 70 years and older with metastatic breast cancer.

Authors: Hyman Muss; Javier Cortes; Linda T Vahdat; Fatima Cardoso; Chris Twelves; Jantien Wanders; Corina E Dutcus; Jay Yang; Seth Seegobin; Joyce O'Shaughnessy
Journal: Oncologist Date: 2014-03-28

3. Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a "standard chemotherapy regimen": the CASA randomized trial.

Authors: Diana Crivellari; Kathryn P Gray; Silvia Dellapasqua; Fabio Puglisi; Karin Ribi; Karen N Price; István Láng; Lorenzo Gianni; Simon Spazzapan; Graziella Pinotti; Jean-Marc Lüthi; Richard D Gelber; Meredith M Regan; Marco Colleoni; Monica Castiglione-Gertsch; Rudolf Maibach; Manuela Rabaglio; Alan S Coates; Aron Goldhirsch
Journal: Breast Date: 2013-02-28 Impact factor: 4.380

Older women with breast cancer: slow progress, great opportunity, now is the time.

1. Patterns of locoregional treatment for nonmetastatic breast cancer by patient and health system factors.

2. Eribulin monotherapy in patients aged 70 years and older with metastatic breast cancer.

3. Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a "standard chemotherapy regimen": the CASA randomized trial.

4. Factors associated with receipt of breast cancer adjuvant chemotherapy in a diverse population-based sample.

Review 5. Treating Elderly Patients With Hormone Receptor-Positive Advanced Breast Cancer.

6. Improving breast cancer services for African-American women living in St. Louis.